Dear %%First_name%%

More than 77% of patients would participate in clinical research if asked, though only 4%-6% of eligible patients currently participate.¹ Reaching these patients is easier through digital channels. And when you connect with potential trial participants from the outset, you can build virtual communities to draw from throughout the development continuum.

I’d like to share our new white paper that explains how engaging the digital patient can yield efficiencies across the biopharma product lifecycle. It’s an innovative approach that can help streamline product development, prove product value, and accelerate product adoption and adherence. Now you can:

• Inform study protocol design by connecting with patients online to determine criteria influence
• Supplement investigator recruitment through the boundless reach of the Internet
• Drive study retention by cultivating long-term patient relationships
• Convert study participants into early adopters and empower them as product advocates
• Support market access by leveraging patient-reported outcomes from clinical trials
• Help patients maintain therapy by understanding what motivates them, providing value-based services and enabling communication and learning

I would be happy to discuss the potential of the digital patient to drive your product’s success. Feel free to contact me, and I’ll be sure to be in touch with you shortly.

Bernadette Tosti
Manager, Digital Patient Unit
Contact by Email
Contact by Phone: 617-460-9784

¹Source: CSICRP, 2013